thyroxine has been researched along with Multiple Endocrine Neoplasia Type 1 in 1 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
Multiple Endocrine Neoplasia Type 1: A form of multiple endocrine neoplasia that is characterized by the combined occurrence of tumors in the PARATHYROID GLANDS, the PITUITARY GLAND, and the PANCREATIC ISLETS. The resulting clinical signs include HYPERPARATHYROIDISM; HYPERCALCEMIA; HYPERPROLACTINEMIA; CUSHING DISEASE; GASTRINOMA; and ZOLLINGER-ELLISON SYNDROME. This disease is due to loss-of-function of the MEN1 gene, a tumor suppressor gene (GENES, TUMOR SUPPRESSOR) on CHROMOSOME 11 (Locus: 11q13).
Excerpt | Relevance | Reference |
---|---|---|
"Two women had sporadic multiple endocrine neoplasia type 1-associated syndrome." | 1.32 | The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients. ( Beckers, A; Chanson, P; Delemer, B; Mockel, J; Rohmer, V; Socin, HV; Stevenaert, A; Tabarin, A, 2003) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Socin, HV | 1 |
Chanson, P | 1 |
Delemer, B | 1 |
Tabarin, A | 1 |
Rohmer, V | 1 |
Mockel, J | 1 |
Stevenaert, A | 1 |
Beckers, A | 1 |
1 other study available for thyroxine and Multiple Endocrine Neoplasia Type 1
Article | Year |
---|---|
The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients.
Topics: Acromegaly; Adenoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Belgium; Femal | 2003 |